Accuray Incorporated logo

Accuray Incorporated (ARAY)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
0. 26
-0.01
-3.7037%
$
31.41M Market Cap
- P/E Ratio
- Div Yield
314,000 Volume
- Eps
$ 0.27
Previous Close
Add Transaction
Day Range
0.25 0.27
Year Range
0.24 2.1
Want to track ARAY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ARAY closed today lower at $0.26, a decrease of -3.7037% from yesterday's close, completing a monthly decrease of -31.5789% or -$0.12. Over the past 12 months, ARAY stock lost -69.0476%.
ARAY is not paying dividends to its shareholders.
The last earnings report, released on May 06, 2026, exceeded the consensus estimates by 0.05%. On average, the company has fell short of earnings expectations by -0.0089%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

ARAY Chart

Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript

Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript

Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
Accuray (ARAY) to Release Quarterly Earnings on Wednesday

Accuray (ARAY) to Release Quarterly Earnings on Wednesday

Accuray (NASDAQ: ARAY - Get Free Report) is anticipated to issue its Q3 2026 results after the market closes on Wednesday, April 29th. Analysts expect the company to announce earnings of ($0.05) per share and revenue of $111.90 million for the quarter. Parties are encouraged to explore the company's upcoming Q3 2026 earning overview page for

Defenseworld | 2 months ago
Accuray Incorporated (ARAY) Q2 2026 Earnings Call Transcript

Accuray Incorporated (ARAY) Q2 2026 Earnings Call Transcript

Accuray Incorporated (ARAY) Q2 2026 Earnings Call Transcript

Seekingalpha | 5 months ago

Accuray Incorporated Investors

Name Quantity Cost Value Profit ($) Gain (%)
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
23,361 $16,688.87 $6,541.08 -$10,147.79 -60.81%
BG
Bart Gancher Intech Investment Management LLC
29,777 $55,150.29 $8,337.56 -$46,812.73 -84.88%
Anthony Scaramucci
Anthony Scaramucci SkyBridge Capital II LLC
5.64M $7.21M $1.57M -$5.65M -78.29%
Joseph Castro
Joseph Castro Nuveen LLC
295,412 $491,116.62 $81,592.79 -$409,523.83 -83.39%
Bobby Adusumilli
Bobby Adusumilli SJS Investment Consulting Inc.
30 $11.64 $8.18 -$3.46 -29.73%

Accuray Incorporated (ARAY) FAQ

What is the stock price today?

The current price is $0.26.

On which exchange is it traded?

Accuray Incorporated is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is ARAY.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 31.41M.

Has Accuray Incorporated ever had a stock split?

No, there has never been a stock split.

Accuray Incorporated Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Stephen R. LaNeve CEO
NASDAQ (NGS) Exchange
004397105 CUSIP
US Country
990 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Accuray Incorporated is a leading innovator in the field of precision radiation oncology, providing advanced radiosurgery and radiation therapy systems worldwide. Founded in 1990 and based in Madison, Wisconsin, the company's pioneering solutions are designed to enhance cancer treatment by targeting tumors with high precision. Accuray’s global reach extends across the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the rest of the Asia Pacific region. The company is committed to improving patient outcomes by offering cutting-edge technology for the treatment of primary and metastatic tumors outside the brain, among other applications. In addition to developing and manufacturing its products, Accuray Incorporated offers a comprehensive range of support services including post-contract customer support, installation, training, and professional services to ensure the effective use and maintenance of its systems.

Products and Services

  • CyberKnife System

This innovative robotic stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) system is at the forefront of Accuray’s offerings. The CyberKnife System is designed for the treatment of primary and metastatic tumors located outside the brain. It is particularly effective for tumors on or near the spine and in regions such as the breast, kidney, liver, lung, pancreas, and prostate. Utilizing robotic technology, the system delivers highly precise treatment, minimizing damage to surrounding healthy tissue.

  • TomoTherapy System, including the Radixact System

The TomoTherapy and Radixact Systems represent a significant advancement in the delivery of radiation therapy, enabling clinicians to perform ultra-precise treatments for a wide range of cancers. These systems feature integrated radiation treatment planning, delivery, and data management capabilities. The high level of precision and efficiency allows for treating approximately 50 patients per day, making it a pivotal tool in high-volume treatment centers.

  • iDMS Data Management System

Accuray’s iDMS Data Management System is designed to enhance the efficiency of treatment planning and delivery by providing a fully integrated suite for managing patient data and treatment plans. This system streamlines the workflow, facilitating a more seamless operation from planning through treatment.

  • Accuray Precision Treatment Planning System

The Accuray Precision Treatment Planning System is tailored to support the detailed and complex planning required for delivering precise radiation therapy. By offering sophisticated data management and planning tools, this system aids clinicians in creating optimized treatment strategies for their patients.

  • Professional Services

In addition to its pioneering technology, Accuray Incorporated provides a comprehensive suite of professional services. These include post-contract customer support, which ensures that all systems are maintained to the highest standards, as well as installation and training services. Through these offerings, Accuray empowers healthcare providers to maximize the benefits of its systems for patients, thereby enhancing treatment outcomes and operational efficiency.

Contact Information

Address: 1240 Deming Way
Phone: 608 824 2800